MAREZINE Drug Patent Profile
✉ Email this page to a colleague
When do Marezine patents expire, and what generic alternatives are available?
Marezine is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in MAREZINE is cyclizine lactate. Additional details are available on the cyclizine lactate profile page.
Summary for MAREZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 4,348 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MAREZINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MAREZINE
US Patents and Regulatory Information for MAREZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | MAREZINE | cyclizine lactate | INJECTABLE;INJECTION | 009495-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |